

Good Medicine Podcast
Good Medicine Podcast
The science behind what makes medicine...good
Episodes
Mentioned books

Aug 12, 2025 • 52min
Transforming Therapeutics & Diagnostics: How Seek Labs is Putting Patients First | Jared Bauer & Dr. Alison O’Mahony
This week on the Good Medicine Podcast, Dr. David Bearss sits down with Jared Bauer and Dr. Alison O’Mahoney of Seek Labs, a therapeutic & diagnostics company on a mission to make healthcare faster, more accessible, and more patient-centered.In this conversation, they explore how the world of infectious diseases is evolving and why historical approaches to diagnostics no longer meet the needs of modern healthcare. Alison discusses how global changes are reshaping how diseases emerge and spread, and what that means for treatment. Jared shares Seek’s experience tackling African Swine Fever and how that project exemplified their impact and adaptability.Throughout the episode, a clear theme emerges: a relentless focus on the patient. From product design to company decisions, the patient’s safety and wellbeing guide everything Seek Labs does.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Aug 5, 2025 • 1h 1min
How Diagnostics Are Reshaping the Future of Medicine | Dr. Gregory Critchfield
This week on Good Medicine, Dave Bearss sits down with Dr. Gregory Critchfield—former president of Myriad Genetics and a leader in the diagnostics space—to explore how diagnostic tools are transforming healthcare.From early disease detection to precision medicine, Dr. Critchfield shares insights from decades of experience and breaks down where diagnostics are headed next. The conversation touches on the business of diagnostics, the challenges of clinical adoption, and how emerging technologies are changing the game for patients and providers alike.Whether you're a scientist, investor, or just curious about how medicine is evolving, this episode offers a fascinating look into the power and potential of diagnostics.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jul 29, 2025 • 43min
The Fire Within: Why Chronic Inflammation Is the Root of Modern Disease| Dr. Jeremiah Bearss
In this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a revealing discussion on one of the most important—and misunderstood—topics in modern health: chronic inflammation. Together, they unpack the crucial difference between acute and chronic inflammation, explain why long-term inflammation is a silent driver behind a wide range of serious diseases, and explore how shifting our medical approach could transform outcomes.Whether you're a healthcare professional, wellness enthusiast, or someone navigating chronic illness, this episode offers powerful insights into the role inflammation plays in everything from heart disease to neurodegeneration—and why understanding it could be the key to prevention.

Jul 22, 2025 • 59min
Protecting Biotech Innovation: Patent Insights | Matt Bresnahan
In this episode of Good Medicine, Dr. David Bearss sits down with Matt Bresnahan, a partner at Wilson Sonsini Goodrich & Rosati, to demystify the world of patents in biotech and life sciences. Together, they explore what makes an innovation patent-eligible, how the 21-year patent timeline works, and how the U.S. patent system incentivizes solving unmet medical needs—ultimately helping patients access breakthrough drugs at lower costs.Whether you're a biotech founder, researcher, or just curious about how innovation becomes accessible medicine, this episode offers clear, practical insight into one of the most important—but misunderstood—parts of the life sciences ecosystem.🔗 New episodes every Tuesday. Subscribe to stay in the loop on healthcare, innovation, and policy.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jul 15, 2025 • 43min
How Australia Is Reshaping Clinical Trials | Daniel Evans
Dr. David Bearss sits down with Daniel Evans of Southern Star Research to explore how Australia is becoming a global leader in Phase 1 clinical trials. They discuss how the country’s streamlined regulatory environment and government incentives are helping biotech companies move faster and more efficiently. Australia’s bold approach is challenging outdated global standards. If you’re in biotech, pharma, or curious about the future of clinical research, this episode offers a glimpse into a more agile, innovative path forward.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jul 8, 2025 • 52min
The Obesity Crisis & GLP-1 Drugs | A Candid Conversation Between Brothers
On this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a raw and insightful conversation about obesity, weight loss, and the explosive rise of GLP-1 drugs.Together, they explore:The personal and societal toll of obesityHow GLP-1 medications are reshaping the weight loss landscapeThe science behind these treatments — and the hypeWhy lifestyle still matters, even in a pharmaceutical eraSubscribe for more real, honest conversations about health, innovation, and the future of medicine.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jul 1, 2025 • 1h 2min
Vocal Biomarkers & Disease Detection | Henry O'Connell
This week on Good Medicine, we sit down with Henry O’Connell, CEO of Canary Speech, a company using vocal biomarkers to revolutionize mental and neurological health diagnostics.With a career spanning leadership roles at NIH, HP, and MOXTEK, Henry brings decades of insight into how technology can transform healthcare. In this episode, he explains how Canary’s voice analysis tools are giving doctors a clearer picture of patient health, removing global bias from diagnostics, and helping parents better support their kids’ emotional well-being.🔍 We explore:How vocal data can complement traditional medical toolsThe role of AI in detecting mental health conditionsMaking healthcare more equitable across cultures and regionsEmpowering parents with real-time emotional insightsWhether you're a clinician, innovator, or just curious about the future of healthcare, this conversation offers a fascinating look at how something as simple as your voice could shape the next era of medicine.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jun 24, 2025 • 58min
Founding Scientia and What Drives Him | John Lippert
In this episode of Good Medicine, David Bearss sits down with John Lippert, founder and Chief Technology Officer at Scientia. With a career spanning decades in the medical device industry, John shares insights from his work in neurovascular innovation, startup leadership, and the evolution of less-invasive medicine. As the founder of both Scientia Vascular and Precision Vascular Systems—and with a background at leading companies like Target Therapeutics and Advanced Cardiovascular Systems—John brings a rare depth of technical expertise and entrepreneurial vision.We explore his impressive portfolio of patents, his approach to building breakthrough technologies, and the values that have guided his journey from engineer to industry leader.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jun 17, 2025 • 60min
Medical Devices & Strokes | Mark Paul
In this episode of Good Medicine, Dr. Bearss sits down with Mark Paul, a veteran of the medical device industry, to explore the intersection of innovation, engineering, and patient care.Mark shares lessons from a decades-long career — from early product development to scaling companies that have improved countless lives. He reflects on the mindset needed to lead teams, solve real-world problems, and bring new devices to market. It's a rare look behind the curtain of medtech from someone who’s lived it.Whether you're an engineer, healthcare investor, startup founder, or just fascinated by the tools that keep people alive and thriving, this is an episode packed with insight and inspiration.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Jun 10, 2025 • 32min
The FDA and NIH: What Works, What Doesn’t | Dr. David Bearss
This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and public trust—while also examining the growing debates around how they operate. From differing perspectives across industry, academia, and government, Dave unpacks the complex views on what should evolve and why it matters.Whether you're in biotech, policy, or just curious about the forces shaping medicine, this episode offers a grounded, insightful look at two of the most influential organizations in health.SponsorsBioHive: https://www.biohive.comGalvan: https://www.galvan.healthFollow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePodTikTok: https://www.tiktok.com/@good.medicine.podcastLinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/